Search Results 351-360 of 14781 for anti-TNF drugs

  1. A Phase 1 Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic Health ... treatment with an anti LAG-3 or anti TIM-3 is also excluded; Known ...

  2. Pexidartinib (Oral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Turalio. Descriptions. Pexidartinib is used to treat ...

  3. Triamcinolone (Topical Application Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Aristocort A; Cinolar; Dermasorb TA Complete Kit; Kenalog ...

  4. Infliximab-Axxq (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. Fentanyl (Transdermal Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  6. Data From Worldwide Trial of Two HER2-Positive Breast Cancer Drugs Shows That Trastuzumab Should Remain as Standard of Care - Mayo Clinic News Network

    Dual blockade using two anti-HER2 drugs only increased toxicity, said Dr. Perez. This new analysis compared use of lapatinib or trastuzumab alone, as well ...

  7. Acute coronary syndrome - Diagnosis and treatment - Mayo Clinic

    Medicines · Clot busters help break up a blood clot that's blocking an artery. · Nitroglycerin improves blood flow by temporarily widening blood vessels. · Anti- ...

  8. A Study to Identify a Panel of Biomarkers to Predict Response to Anti PD-1 Therapy - Mayo Clinic

    The purpose of this study is to identify a panel of possible biomarkers to predict response to anti PD-1 therapy by establishing the progression free survival ...

  9. Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome - Mayo Clinic

    Giving duvelisib in combination with nivolumab may work better than giving each of these drugs ... methotrexate, azathioprine, anti-tumor necrosis factor (TNF) ...

  10. Randomized Study of Topical Alicaforsen Enema in Antibiotic Refractory Pouchitis - Mayo Clinic

    ... therapy. Rectal products; Biological agents: Anti-tumour necrosis factor (anti - TNF) therapy and / or vedolizumab; are not permitted within 8 weeks of the ...